When it comes to breast cancer, new Enhertu research may allow an ADC to surpass chemotherapy
About two years back, Enhertu, a medication, reshaped doctor’s approach to a hostile type of breast cancer. It highlighted the importance of understanding not only the presence of the HER2 protein in patients’ tumors but also the extent of it.